title: [Analysis of indications and results of surgical treatment for patients with pulmonary metastasis].
abstract: Ninety-three patients with pulmonary metastases (PM) were operated on between 1983 and 1997. Surgical complications occurred in 8 (9%) of patients. Two (3%) of patients died in hospital, 7 were operated on again due to further PM. An average survival after lung metastasis surgery was 40 months, median 22 months. 44% and 35% of patients survived respectively 3 and 5 years. Thanks to lung metastasis surgery the overall survival was longer; an average overall survival was 87 months (median 58 months). 58% and 38% of patients survived respectively 5 and 10 years. Time between treatment of primary tumour (PT) and lung metastasis surgery (disease free interval DFI) was on average 4 years, median 41 months. The patients who showed DFI-longer than 2 years had tendency to live longer (p = 0.086). Patients with PM are recommended to be operated on, even if further PM occur.
authors.affiliation: Kliniki Chirurgii Onkologicznej, Centrum Onkologii Oddział w Krakowie.
authors.forename: L
authors.initials: L
authors.lastname: Kołodziejski
authors.forename: J
authors.initials: J
authors.lastname: Góralczyk
authors.forename: S
authors.initials: S
authors.lastname: Dyczek
authors.forename: K
authors.initials: K
authors.lastname: Duda
authors.forename: H
authors.initials: H
authors.lastname: Dymek
authors.forename: T
authors.initials: T
authors.lastname: Nabiałek
mesh_terms: D000230:Adenocarcinoma / Q000556:secondary; D000293:Adolescent; D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000556:secondary; D005260:Female; D018237:Germinoma / Q000556:secondary; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D008297:Male; D008545:Melanoma / Q000556:secondary; D008875:Middle Aged; D012509:Sarcoma / Q000556:secondary; D015996:Survival Rate